ProfileGDS5822 / ILMN_3157232
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 16% 3% 58% 0% 13% 40% 31% 21% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 111.916
GSM1276600PDAC Late Ablation Control 28.63
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 124.558
GSM1276603PDAC Late Ablation 20.70
GSM1276604PDAC Late Ablation 39.413
GSM1303940PDAC Late Ablation_anti-CTLA4 118.640
GSM1303941PDAC Late Ablation_anti-CTLA4 215.331
GSM1303942PDAC Late Ablation_anti-CTLA4 31121